Recombinant human, active site-blocked factor VIIa reduces infarct size and no-reflow phenomenon in rabbits

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 278, Issue 5 47-5, 2000, Pages

  Golino, Paolo ^a   Ragni, Massimo ^a   Cirillo, Plinio ^a   Scognamiglio, Annalisa ^a   Ravera, Amelia ^a   Buono, Chiara ^a   Guarino, Angela ^a   Piro, Orlando ^a   Lambiase, Catello ^a   Botticella, Filomena ^a   Ezban, Mirella ^b   Condorelli, Mario ^a   Chiariello, Massimo ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b NOVO NORDISK A S   (Denmark)

Author keywords

Active site blocked activated factor VII; Extrinsic coagulation pathway; Reperfusion injury

Indexed keywords

BLOOD CLOTTING FACTOR 7A; FREE RADICAL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD CLOTTING; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; ENZYME ACTIVE SITE; FEMALE; HEART INFARCTION SIZE; HEART MUSCLE INJURY; HEART MUSCLE ISCHEMIA; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RABBIT; REPERFUSION INJURY;

EID: 0034042062     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.2000.278.5.h1507     Document Type: Article

References (40)

1. Ambrosio G, Flaherty JT, Duilio C, Tritto I, Santoro G, Elia PP, Condorelli M, and Chiariello M. Oxygen radicals generated at reflow induce peroxidation of membrane lipids in reperfused hearts. J Clin Invest 87: 2056-2066, 1991.
2. Ambrosio G, Weisman HF, Mannisi JA, and Becker LC. Progressive impairment of regional myocardial perfusion after initial restoration of postischemic blood flow. Circulation 80: 1846-1861, 1989.
3. Annex BH, Denning SM, Channon KM, Sketch MH, Stack RS, Morrissey JH, and Peters KG. Differential expression of tissue factor protein in directional atherectomy specimens from patients with stable and unstable coronary syndromes. Circulation 91: 619-622, 1995.
4. Chatelain P, Labour J-G, Tran D, deLorgeril M, Dupras G, and Bourassa M. Neutrophil accumulation in experimental myocardial infarcts: relation with extent of injury and effect of reperfusion. Circulation 75: 1083-1090, 1987.
5. Colucci M, Balconi G, Lorenzet R, Pietra A, Locati D, Donati MB, and Semeraro N. Cultured human endothelial cells generate tissue factor in response to endotoxin. J Clin Invest 71: 1893-1896, 1983.
6. Connelly C, Vogel WM, Hernandez YM, and Apstein CS. Movement of necrotic wavefront after coronary artery occlusion in rabbit. Am J Physiol Heart Circ Physiol 243: H682-H690, 1982.
7. Crossman DC, Carr DP, Tuddenham EGD, Pearson JD, and McVey JH. The regulation of tissue factor mRNAin human endothelial cells in response to endotoxin or phorbol ester. J Biol Chem 265: 9782-9787, 1990.
8. Engler RL, Dahlgren MD, Morris D, Peterson MA, and Schmid-Schoenbein G. Role of leukocytes in the response to acute myocardial ischemia and reflow in dogs. Am J Physiol Heart Circ Physiol 251: H314-H323, 1986.
9. Engler RL, Dahlgren MD, Peterson MA, Dobbs A, and Schmid-Schoenbein G. Accumulation of polymorphonuclear leukocytes during 3 h experimental myocardial ischemia. Am J Physiol Heart Circ Physiol 251: H93-H100, 1986.
10. Engler RL, Schmid-Schoenbein G, and Pavelec RS. Leukocyte capillary plugging in myocardial ischemia and reperfusion in the dog. Am J Pathol 111: 98-111, 1983.
11. Fishbein MC, Meerbaum S, Rit J, Lando U, Kanmatsuse K, Mercier JC, Corday E, and Ganz W. Early phase acute myocardial infarct size quantification: validation of the triphenyltetrazolium chloride tissue enzyme staining technique. Am Heart J 101: 593-601, 1981.
12. Forrester JS. New standard for success of thrombolytic therapy. Circulation 92: 2026-2028, 1996.
13. Girard TJ, Warren LA, Novotny WF, Likert KM, Brown SG, Miletich JP, and Broze GJ. Functional significance of the Kunitz-type inhibitory domains of lipoprotein-associated coagulation inhibitor. Nature 338: 518-520, 1989.
14. Golino P, Ambrosio G, Ragni M, Pascucci I, Triggiani M, Oriente A, McNatt J, Buja LM, Condorelli M, Chiariello M, and Willerson JT. Short-term and long-term role of platelet-activating factor as a mediator of in vivo platelet aggregation. Circulation 88: 1205-1214, 1993.
15. Golino P, Ambrosio G, Villari B, Ragni M, Focaccio A, Pace L, De Clerck F, Condorelli M, and Chiariello M. Endogenous prostaglandin endoperoxides may alter infarct size in the presence of thromboxane synthase inhibition: studies in a rabbit model of coronary artery occlusion-reperfusion. J Am Coll Cardiol 21: 493-501, 1993.
16. Golino P, Maroko PR, and Carew TE. The effects of acute hypercholesterolemia on myocardial infarct size and the noreflow phenomenon during coronary occlusion-reperfusion. Circulation 75: 292-298, 1987.
17. Golino P, Ragni M, Cirillo P, Avvedimento VE, Feliciello A, Esposito N, Scognamiglio A, Trimarco B, Iaccarino G, Condorelli M, Chiariello M, and Ambrosio G. Effects of tissue factor induced by oxygen free radicals on coronary flow during reperfusion. Nat Med 2: 35-41, 1996.
18. Golino P, Ragni M, Cirillo P, D'Andrea Scognamiglio D, Ravera A, Buono C, Ezban M, Corcione N, Vigorito F, Condorelli M, and Chiariello M. Antithrombotic effects of recombinant human, active site-blocked factor Vila in a rabbit model of recurrent arterial thrombosis. Circ Res 82: 39-46, 1998.
19. Golino P, Ragni M, Cirillo P, Esposito N, Battaglia C, Guarino A, and Ramunno L. Role of tissue-factor pathway inhibitor as a natural inhibitor of intravascular thrombus formation in a rabbit model of carotid artery thrombosis (Abstract). Circulation 92: I486, 1995.
20. GUSTO Investigators. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med 329: 673-682, 1993.
21. Halliwell B. Oxidants and human disease: some new concepts. FASEB J 1: 358-364, 1987.
22. Kloner RA, Ganote CE, and Jennings RB. The "no-reflow" phenomenon after temporary coronary occlusion in the dog. J Clin Invest 54: 1496-1503, 1974.
23. Kowallik P, Schultz R, Guth BD, Schade A, Paffhausen W, Gross R, and Heusch G. Measurement of regional myocardial blood flow with multiple colored microspheres. Circulation 83: 974-982, 1991.
24. Krug A, deRochemont WM, and Korb G. Blood supply of the myocardium after temporary coronary occlusion. Circ Res 19: 57-62, 1966.
25. Lieu TA, Gurley RJ, Lundstrom RJ, and Parmley WW. Primary angioplasty and thrombolysis for acute myocardial infarction: an evidence summary. J Am Coll Cardiol 27: 737-750, 1996.
26. McCord JM. Oxygen-derived free radicals in postischemic tissue injury. N Engl J Med 312: 159-163, 1985.
27. Nawroth PP, Handley DA, Esmon CT, and Stern DM. Interleukin-1 induces endothelial cell procoagulant while suppressing cell-surface anticoagulant activity. Proc Natl Acad Sci USA 83: 3460-3465, 1986.
28. Pawashe AB, Golino P, Ambrosio G, Migliaccio F, Ragni M, Pascucci I, Chiariello M, Bach R, Garen A, Konigsberg WK, and Ezekowitz MD. A monoclonal antibody against rabbit tissue factor inhibits thrombus formation in stenotic injured rabbit carotid arteries. Circ Res 74: 56-63, 1994.
29. Ragni M, Cirillo P, Pascucci I, Scognamiglio A, D'Andrea D, Eramo N, Ezekowitz MD, Pawashe AB, Chiariello M, and Golino P. A monoclonal antibody against tissue factor shortens tissue-plasminogen activator lysis time and prevents reocclusion in a rabbit model of carotid artery thrombosis. Circulation 93: 1913-1920, 1996.
30. Rapaport SI and Rao LVM. Initiation and regulation of tissue factor-dependent blood coagulation. Arterioscler Thromb 12: 1111-1121, 1992.
31. Rapaport SI and Rao LVM. The tissue factor pathway: how it has become a "prima ballerina." Thromb Haemost 74: 7-17, 1995.
32. Reimer KA, Jennings RB, Cobb FR, Murdock RH, Greenfield JC, Becker LC, Bulkley BH, Hutchins GM, and Schwartz RP Jr. Animal models for protecting ischemic myocardium (AMPIM): results of the NHLBI cooperative studies: comparison of the unconscious and conscious dog models. Circ Res 56: 651-665, 1985.
33. Schosser R, Arfors K-E, and Messmer K. MIC-II - a program for the determination of cardiac output, arterio-venous shunt and regional blood flow using the radioactive microsphere method. Comput Programs Biomed 9: 19-38, 1979.
34. Simpson PJ, Todd RF III, Fantone JC, Mickelson JK, Griffin JD, and Lucchesi BR. Reduction of experimental canine myocardial reperfusion injury by a monoclonal antibody (anti Mol, anti CD11b) that inhibits leukocyte adhesion. J Clin Invest 81: 624-629, 1988.
35. Sørensen BB, Persson E, Freskgård PO, Kjalk M, Ezban M, Williams T, and Rao LMV. Incorporation of an active site inhibitor in factor VIIa alters the affinity for tissue factor. J Biol Chem 272: 11863-11868, 1997.
36. Thakur ML, Welch MJ, Joist JH, and Coleman RE. Indium-111-labeled platelets: studies on preparation and evaluation of in vitro and in vivo functions. Thromb Res 9: 345-352, 1976.
37. Toschi V, Gallo R, Lettino M, Fallon JT, Gertz SD, Fernanànder-Ortiz A, Chesebro JH, Badimon L, Nemerson Y, Fuster V, and Badimon JJ. Tissue factor modulates the thrombogenicity of human atherosclerotic plaques. Circulation 95: 594-599, 1997.
38. Wilcox JN, Smith KM, Schwartz S, and Gordon D. Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque. Proc Natl Acad Sci USA 86: 2839-2843, 1989.
39. Zweier JL, Flaherty JT, and Weisfeldt ML. Direct measurements of free radical generation following reperfusion of ischemic myocardium. Proc Natl Acad Sci USA 84: 1404-1407, 1987.
40. Zweier JL, Kuppusamy P, Williams WE, Rayburn BK, Smith D, Weisfeldt ML, and Flaherty JT. Measurement and characterization of postischemic free radical generation in the isolated perfused heart. J Biol Chem 264: 18890-18895, 1989.